Capstone Holding Corp. announced its second quarter 2025 financial results and strategic highlights, including substantial gross margin expansion and that it has executed an agreement today that it expects to close in the next 10 days for its first acquisition. The acquisition of a Carolina Based Stone Company will be immediately accretive and extend the company’s reach into the high-growth Southeast market and expand Instone’s distribution platform. Q2 2025 results reflect continued execution on the Company’s strategy of organic growth, margin expansion, and earnings-accretive acquisitions. The team is focused on delivering on our target of a $100M revenue run-rate by year-end 2025 or Q1 2026. “It was an exciting quarter for Capstone. We’re advancing our acquisition of a Carolina Based Stone Company – a transaction that will be immediately accretive to revenue and EBITDA – and will expand our footprint into one of the fastest-growing markets in the country,” said Matthew Lipman, Chief Executive Officer. “We also grew gross margin to 24.4% from 21.4% a year ago, reflecting increased sales of our owned brands and disciplined cost control. Altogether, we’re executing on both pillars of our strategy: expanding through high-quality, earnings-accretive acquisitions and strengthening profitability.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPS:
- Capstone Therapeutics Adjusts Convertible Note Conversion Price
- Capstone Holding Corp. Delays 10-Q Filing
- Capstone Therapeutics Secures $3M for Strategic Acquisition
- Capstone Therapeutics files to sell 4.08M shares of common stock for holders
- Capstone announces formation of Corporate Development team